Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients

Title
Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients
Authors
Keywords
COVID-19, mRNA vaccine, antibody response, immunogenicity, lung transplantation
Journal
JOURNAL OF HEART AND LUNG TRANSPLANTATION
Volume 40, Issue 8, Pages 754-758
Publisher
Elsevier BV
Online
2021-05-22
DOI
10.1016/j.healun.2021.05.004

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation